×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


This case describes the treatment of a CTO to LAD. 

Protocol

  • Procedure time: 75 min
  • Exposure time: 25 min
  • Exposure: 802,20 mGy
  • Contrast volume: 110 ml visipaque 350

Objectives: to learn

- how to use ultra thin struts stent

- how to antegradely approach a CTO lesion

- how to use a trapper

-IVUS use in CTO

Shooting date : 2019-04-10
Last update : 2020-03-04
3 comments
Join the Discussion
  • yilmaz M. congratulations. the flow of LAD is quite good but there is serious stenosis at the ostium of the Diagonal branch. It is an important branch. therefore it is not appropriate to leave the patient in this way in terms of complete revascularization of the patient. I would open the side branch.

    • Hassaan A. I think there is data that supports that if there is TIMI 3 flow in the Diagonal branch its best to leave it alone

    Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
    Your browser doesn't have Flash, Silverlight or HTML5 support.


  • Tekten T.

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Wednesday, May 22nd 2024 from 03pm to 04pm (GMT+2)
    Honolulu : Wednesday, May 22nd 2024 from 04am to 05am (GMT+2)
    San Francisco : Wednesday, May 22nd 2024 from 07am to 08am (GMT+2)
    New York : Wednesday, May 22nd 2024 from 10am to 11am (GMT+2)
    Buenos Aires : Wednesday, May 22nd 2024 from 11am to 12pm (GMT+2)
    Reykjavik : Wednesday, May 22nd 2024 from 02pm to 03pm (GMT+2)
    London / Dublin : Wednesday, May 22nd 2024 from 03pm to 04pm (GMT+2)
    Paris / Berlin : Wednesday, May 22nd 2024 from 04pm to 05pm (GMT+2)
    Istanbul : Wednesday, May 22nd 2024 from 05pm to 06pm (GMT+2)
    Moscou / Dubaï : Wednesday, May 22nd 2024 from 06pm to 07pm (GMT+2)
    Bangkok : Wednesday, May 22nd 2024 from 09pm to 10pm (GMT+2)
    Shanghai : Wednesday, May 22nd 2024 from 10pm to 11pm (GMT+2)
    Tokyo : Wednesday, May 22nd 2024 from 11pm to 12am (GMT+2)
    Sydney : Thursday, May 23rd 2024 from 01am to 02am (GMT+2)
    Wellington : Thursday, May 23rd 2024 from 03am to 04am (GMT+2)

    DanGER shock trial results and the significance to reduce adverse events

    Share
    Tuesday, June 28th 2022 from 12:30pm to 01:50pm (GMT+2)
    Honolulu : Tuesday, June 28th 2022 from 01:30am to 02:50am (GMT+2)
    San Francisco : Tuesday, June 28th 2022 from 04:30am to 05:50am (GMT+2)
    New York : Tuesday, June 28th 2022 from 07:30am to 08:50am (GMT+2)
    Buenos Aires : Tuesday, June 28th 2022 from 08:30am to 09:50am (GMT+2)
    Reykjavik : Tuesday, June 28th 2022 from 11:30am to 12:50pm (GMT+2)
    London / Dublin : Tuesday, June 28th 2022 from 12:30pm to 01:50pm (GMT+2)
    Paris / Berlin : Tuesday, June 28th 2022 from 01:30pm to 02:50pm (GMT+2)
    Istanbul : Tuesday, June 28th 2022 from 02:30pm to 03:50pm (GMT+2)
    Moscou / Dubaï : Tuesday, June 28th 2022 from 03:30pm to 04:50pm (GMT+2)
    Bangkok : Tuesday, June 28th 2022 from 06:30pm to 07:50pm (GMT+2)
    Shanghai : Tuesday, June 28th 2022 from 07:30pm to 08:50pm (GMT+2)
    Tokyo : Tuesday, June 28th 2022 from 08:30pm to 09:50pm (GMT+2)
    Sydney : Tuesday, June 28th 2022 from 10:30pm to 11:50pm (GMT+2)
    Wellington : Wednesday, June 29th 2022 from 12:30am to 01:50am (GMT+2)

    Addressing complexity & unmet needs in modern day PCI

    Share
    Thursday, April 11th 2019 from 12:30pm to 02pm (GMT+2)
    Honolulu : Thursday, April 11th 2019 from 01:30am to 03am (GMT+2)
    San Francisco : Thursday, April 11th 2019 from 04:30am to 06am (GMT+2)
    New York : Thursday, April 11th 2019 from 07:30am to 09am (GMT+2)
    Buenos Aires : Thursday, April 11th 2019 from 08:30am to 10am (GMT+2)
    Reykjavik : Thursday, April 11th 2019 from 11:30am to 01pm (GMT+2)
    London / Dublin : Thursday, April 11th 2019 from 12:30pm to 02pm (GMT+2)
    Paris / Berlin : Thursday, April 11th 2019 from 01:30pm to 03pm (GMT+2)
    Istanbul : Thursday, April 11th 2019 from 02:30pm to 04pm (GMT+2)
    Moscou / Dubaï : Thursday, April 11th 2019 from 03:30pm to 05pm (GMT+2)
    Bangkok : Thursday, April 11th 2019 from 06:30pm to 08pm (GMT+2)
    Shanghai : Thursday, April 11th 2019 from 07:30pm to 09pm (GMT+2)
    Tokyo : Thursday, April 11th 2019 from 08:30pm to 10pm (GMT+2)
    Sydney : Thursday, April 11th 2019 from 10:30pm to 12am (GMT+2)
    Wellington : Friday, April 12th 2019 from 12:30am to 02am (GMT+2)

    Designed for challenging cases - the role of ultrathin DES

    Live from UZ Leuven, Belgium

    Share

    Severe tortuous RCA and calcified LAD

    Dr Johan Bennett, Dr. Ariel Roguin & Dr Eugenio La Scala

    Share

    Complex PCI made easy by physiology

    Dr Johan Bennett, Dr. Ariel Roguin, Dr Eugenio La Scala & Dr Keir McCutcheon

    Share
    Scroll Up